The bill HB4834 amends the Illinois Controlled Substances Act, impacting the Prescription Monitoring Program for controlled substances by excluding testosterone from reporting requirements. It also includes regulations on reporting controlled substance dispensing and exemptions for licensed veterinarians. The bill provides for the purging of existing information concerning the prescribing or dispensing of testosterone from the Prescription Monitoring Program records by January 1, 2027, and prohibits the creation or maintenance of such records beyond that date. The bill further outlines rules for the integration of Electronic Health Records Systems and Pharmacy Management Systems with the Prescription Monitoring Program. It takes effect upon becoming law.